Table 1.
Long-term follow-up of FMT recipients from the FECAL trial.
| Inclusion | |
| Number of patients: | 34 |
| Number of cured patients: | 30 (88%) |
| Average age in years at inclusion (SD): | 71.7 (11.6) |
| Charlson comorbidity index (SD): | 2.53 (2.1) |
| Karnofsky performance status (SD): | 51 (18) |
| Mean number of FMTs given: | 1.26 |
| Follow-up | |
| Number of patients still alive: | 7 (21%) |
| Mean duration of follow-up in years (range): | 4.5 (0.1–11) |
| Mean duration of follow-up in years (range) of patients still alive: | 10.5 (9.5–11) |
| New episodes of CDI: | 4 (12%) |
| Course of non-CDI antibiotics: | 29 (85%) |
| Long-term complications of FMT: | 0 |
| Long-term complications of CDI: | 1 (3%) |
| Lost to follow-up *: | 3 (9%) |
| Onset of new autoimmune or gastrointestinal (GI) disorders: | 0 |
* Three patients were healthy 2 years after FMT, but were lost to further follow-up. Abbreviations: CDI: Clostridioides difficile infection, FMT: fecal microbiota transplantation, SD: standard deviation.